GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...
Despite massive advancements in Cancer treatment in the last few decades, Cancer still remains one of the most fatal ...
Like all hardworking things, the cytotoxic T lymphocytes (CTLs) of the immune system charged with detecting and destroying ...
News Medical on MSN
Soaking up the anti-cancer properties of a South Korean sea sponge
Yale chemists have synthesized a complex, potentially cancer-fighting molecule found in sea sponges discovered off the coast of South Korea. The ...
Race Oncology has discovered the unique molecular mechanism of action for its RC220 therapy, opening two new major potential ...
MedPage Today on MSN
GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients
In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...
In the waters off South Korea, a modest sea sponge produces a molecule so unusual that chemists spent 14 years trying to make ...
News Medical on MSN
Development of therapeutic cancer vaccines based on cancer immunity cycle
Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...
Tb-161 antitumor activity driven by the dual emission of beta particles and Auger electrons ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...
Accession Therapeutics doses first patient in phase 1 trial of TROCEPT-01, a novel cancer immunotherapy: Oxford, UK Tuesday, November 18, 2025, 13:00 Hrs [IST] Accession Therapeut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results